Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits
Portfolio Pulse from Nabaparna Bhattacharya
The rising demand for weight-loss medications like Novo Nordisk's Ozempic and Eli Lilly's Mounjaro has led to a surge in counterfeit drugs. Both companies are working with organizations like the Pharmaceutical Security Institute and law enforcement to combat this issue. Counterfeit versions of these drugs have been intercepted in over a dozen countries, posing significant health risks.
October 22, 2023 | 1:56 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly is also dealing with a rise in counterfeit versions of its weight-loss drug, Mounjaro. The company is taking measures to prevent major counterfeiters of its products.
The rise in counterfeit drugs could negatively impact Eli Lilly's reputation and sales. The company's proactive measures to prevent counterfeiting demonstrate its commitment to product safety and efficacy.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Novo Nordisk is facing a surge in counterfeit versions of its weight-loss medication, Ozempic. The company is working with law enforcement and other organizations to tackle this issue.
The surge in counterfeit drugs could potentially harm Novo Nordisk's reputation and sales if not addressed effectively. The company's efforts to combat this issue show its commitment to ensuring the safety and efficacy of its products.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100